PHIO PHARMACEUTICALS CORP. Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
PHIO PHARMACEUTICALS CORP. (PHIO) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 5 shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2026-03-05
- PHIO PHARMACEUTICALS CORP. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-12-31 was 0.00 shares.
- PHIO PHARMACEUTICALS CORP. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2018-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- PHIO PHARMACEUTICALS CORP. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2017-12-31 was 2.94K shares, a 82.18% decline year-over-year.
- PHIO PHARMACEUTICALS CORP. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2017-09-30 was 14.85K shares.
- PHIO PHARMACEUTICALS CORP. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2025 was 5.00 shares, a 75.00% decline from fiscal 2024.
- PHIO PHARMACEUTICALS CORP. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2024 was 20.00 shares.
- PHIO PHARMACEUTICALS CORP. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2017 was 20.33K shares, a 23.02% increase from fiscal 2016.
- PHIO PHARMACEUTICALS CORP. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2016 was 16.52K shares, a 79.77% decline from fiscal 2015.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | 5.00 shares 10-K · filed 2026-03-05 | |||||
| 2025-09-30 | 5.00 shares 10-Q · filed 2025-11-13 | ||||||
| 2024-12-31 | 20.00 shares 10-K · filed 2026-03-05 | ||||||
| 2018-03-31 | 0.00 shares 10-Q · filed 2018-05-10 | 2.94K shares derived: sum of 2 quarters · filed 2018-05-10 | 17.79K shares derived: sum of 3 quarters · filed 2018-05-10 | 18.32K shares derived: sum of 4 quarters · filed 2018-05-10 | |||
| 2017-12-31 | 2.94K shares derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-03-26 | 17.79K shares derived: sum of 2 quarters · filed 2018-03-26 | 18.32K shares derived: sum of 3 quarters · filed 2018-03-26 | 20.33K shares 10-K · filed 2018-03-26 | |||
| 2017-09-30 | 14.85K shares derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2018-03-26 | 15.38K shares derived: sum of 2 quarters · filed 2018-03-26 | 17.38K shares 10-Q/A · filed 2018-03-26 | 173.82K shares 10-Q · filed 2017-11-08 | 33.91K shares derived: sum of 4 quarters · filed 2018-03-26 | ||
| 2017-06-30 | 533.00 shares derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2018-03-26 | 2.54K shares 10-Q/A · filed 2018-03-26 | 25.38K shares 10-Q · filed 2017-08-10 | 19.06K shares derived: sum of 3 quarters · filed 2018-03-26 | 19.06K shares derived: sum of 4 quarters · filed 2018-03-26 | ||
| 2017-03-31 | 2.00K shares 10-Q/A · filed 2018-03-26 | 20.05K shares 10-Q · filed 2017-05-11 | 18.53K shares derived: sum of 2 quarters · filed 2018-03-26 | 18.53K shares derived: sum of 3 quarters · filed 2018-03-26 | 18.53K shares derived: sum of 4 quarters · filed 2018-03-26 | ||
| 2016-12-31 | 16.52K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | 16.52K shares derived: sum of 2 quarters · filed 2017-03-30 | 16.52K shares derived: sum of 3 quarters · filed 2017-03-30 | 16.52K shares 10-K · filed 2017-03-30 | |||
| 2016-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | 0.00 shares derived: sum of 2 quarters · filed 2016-11-10 | 0.00 shares 10-Q · filed 2016-11-10 | 0.00 shares derived: sum of 4 quarters · filed 2016-11-10 | |||
| 2016-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | 0.00 shares 10-Q · filed 2016-08-11 | 0.00 shares derived: sum of 3 quarters · filed 2016-08-11 | 60.42K shares derived: sum of 4 quarters · filed 2016-08-11 | |||
| 2016-03-31 | 0.00 shares 10-Q · filed 2016-05-12 | 0.00 shares derived: sum of 2 quarters · filed 2016-05-12 | 60.42K shares derived: sum of 3 quarters · filed 2016-05-12 | 81.67K shares derived: sum of 4 quarters · filed 2016-05-12 | |||
| 2015-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | 60.42K shares derived: sum of 2 quarters · filed 2016-03-30 | 81.67K shares derived: sum of 3 quarters · filed 2016-03-30 | 81.67K shares 10-K · filed 2016-03-30 | |||
| 2015-09-30 | 60.42K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | 81.67K shares derived: sum of 2 quarters · filed 2015-11-12 | 81.67K shares 10-Q · filed 2015-11-12 | ||||
| 2015-06-30 | 21.25K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | 21.25K shares 10-Q · filed 2015-08-12 | |||||
| 2015-03-31 | 0.00 shares 10-Q · filed 2015-05-13 | ||||||
| 2014-12-31 | 0.00 shares 10-K · filed 2015-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |